Preferred Label : glucarpidase;

MeSH Related Number : EC 3.4.17.11;

UNII : 2GFP9BJD79;

Details


Main resources

You can consult :


https://ansm.sante.fr/tableau-acces-derogatoire/voraxaze-1000-u-poudre-pour-solution-pour-perfusion
2024
false
false
false
France
French
glucarpidase
drug information

---
https://www.has-sante.fr/jcms/p_3361532/fr/voraxaze-glucarpidase-reduction-de-la-concentration-plasmatique-toxique-de-methotrexate
2022
false
false
false
France
Methotrexate Toxicity
Methotrexate Toxicity
insurance, health, reimbursement
treatment outcome
adult
adolescent
child
methotrexate
methotrexate
glucarpidase
guidelines for drug use
injections, intravenous
evaluation of the transparency committee
glucarpidase
methotrexate
Voraxaze

---
https://www.has-sante.fr/jcms/p_3334621/fr/voraxaze-glucarpidase
https://www.has-sante.fr/jcms/p_3334731/fr/decision-n-2022-0235/dp/sem-du-25-avril-2022-de-la-presidente-de-la-haute-autorite-de-sante-prise-au-nom-du-college-portant-autorisation-d-acces-precoce-de-la-specialite-voraxaze
2022
false
false
false
France
treatment outcome
insurance, health, reimbursement
methotrexate
Methotrexate Toxicity
Methotrexate Toxicity
adult
child
glucarpidase
injections, intravenous
evaluation of the transparency committee
Voraxaze
glucarpidase

---
https://www.ema.europa.eu/en/medicines/human/EPAR/voraxaze-0
2022
false
false
false
Netherlands
French
English
glucarpidase
glucarpidase
glucarpidase
orphan drug production
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
adult
adolescent
infant
aged
Methotrexate toxicity
methotrexate
injections, intravenous
methotrexate
methotrexate
product surveillance, postmarketing
pregnancy
breast feeding
drug interactions
drug evaluation, preclinical

---
Nous contacter.
24/05/2025


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.